Which is more profitable, Amgen or Gilead Sciences?

Gilead Sciences keeps more of every sale as profit.

Which grows faster, Amgen or Gilead Sciences?

Amgen grew its sales faster in recent years.

Which is cheaper, Amgen or Gilead Sciences?

Gilead Sciences costs less for each unit of yearly profit (lower P/E).

Which has less debt, Amgen or Gilead Sciences?

Gilead Sciences would need fewer years of earnings to pay off its debt.

AmgenAMGNvs

Gilead SciencesGILD

Amgen vs Gilead Sciences stock

Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.

In one sentence

Amgen grows faster. Gilead Sciences is more profitable, is cheaper for its profits and has less debt.

Side by side

	Amgen	Gilead Sciences
	$252 billion	$208 billion
	21.0%	28.9%
	+7.6%	+3.6%
	32.7×	24.5×
	2.7 years	1.3 years
	15.0%	18.4%
	2.9%	2.3%

Open Amgen Open Gilead Sciences

How we compare

Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.

More comparisons: Amgen vs Intuitive Surgical · Amgen vs Johnson & Johnson · Amgen vs Eli Lilly · Amgen vs Medtronic · Gilead Sciences vs Johnson & Johnson · Gilead Sciences vs Eli Lilly · Gilead Sciences vs Merck & · Gilead Sciences vs Roche